Emerald Medical Applications Ltd. (DermaCompare)

www.dermacompare.com

High-Tech Company

Merged with Virtual Crypto

Accelerated by: Orange 4G Innovation Lab

TECH VERTICALS

Artificial Intelligence, Augmented Reality, Cloud, Digital Health, Healthcare IT, Healthtech, Image Processing, Life Sciences, Machine Learning, MedTech

General Data

Sector	Digital Health
Company Stage:	Initial Revenues
Established	2010
Number of Employees	16
Reg. Number:	abCDe

DESCRIPTION

Emerald Medical Applications operates in the field of image processing software infrastructure solutions for an extensive range of applications in diverse medical fields. Its first application is DermaCompare, a SaaS cloud-based image processing comparison tool that addresses population-wide screening for melanoma and automates the practice of manual examination of suspicious moles, which hasn’t changed for decades. DermaCompare is a SaaS (Software as a Service) cloud-based, real time auto image processing comparison tool, adapted from military technology used to decipher aerial images. The system is designed as a decision support tool for diagnosis and early detection of skin cancer which will ultimately help prevent the occurrence of Melanoma among more than 420 million people at high risk across the globe

TECHNOLOGY

DermaCompare is a mobile and web SaaS product that supports both Dermatologists (B2B) and patients (B2C) to detect and manage Melanoma anomaly changes. The platform is using Augmented Reality, Machine Learning, Artificial Intelligence as an assistance tool to the physician and the patient.

	TARGET MARKETS
	Skin Cancer clinics, Dermatologists, GPs, 420 million people at high risk across the globe, especially white skin populations in North & South America, Europe, Australia, South Africa.

	BUSINESS MODEL
	B2C

AFFILIATION

Account ID	Affiliation Type	Name	Parent Name	Status
529A8247-B604-E311-B3BE-00237DE91982		Emerald Medical Applications Ltd. (DermaCompare)		Acquired/Merged
8AE7C533-972F-E511-A24C-80C16E7D3630		4SaveU	Emerald Medical Applications Ltd. (DermaCompare)	Ceased

REMARKS

Date	Remark
17/01/2018	Due to lack of revenues, Emeral Medical Ltd. commenced an action in Israel to liquidate Emerald IL. Emerald Medical Inc. established Virtual Crypto Technologies Ltd. and changed its name to Virtual Crypto Technologies Inc.

CONTACT INFO

Expand / Collapse All

Main Address: Petach Tikva, Israel

Address	7 Imber St.
City	Petach Tikva
Country	Israel
Zip	4951141

Contact Person	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

	MANAGEMENT

Key Executive

Name	Title	Previous Position
Ms. Adi Zamir	CEO	Ship Your Innovation (UPS) (Professional Manager)
Dr. Alon Scope	Medical Advisor
Mr. Lior Wayn	Co-Founder
Mr. Tal Wayn	Co-Founder	SeqUR (VP Professional Services)

	BOARD

Board

Member	Title	Affiliation
abC Defghij	Chairman	Former Managing Director, SFK
abC Defghij	Board Member	Senior Financial Advisor, Pioneer International Financial Services

Mergers & Acquisitions

Round

Date

Stage

Amount

Valuation

Merged

Jan. 17, 2018

Initial Revenues

abCDe

Due to lack of revenues, Emeral Medical Ltd. commenced an action in Israel to liquidate Emerald IL. Emerald Medical Inc. established Virtual Crypto Technologies Ltd. and changed its name to Virtual Crypto Technologies Inc.

* New investor

Investor	Type	Amount	Remarks
abC Defghij	High-Tech Company	abCDe

Reverse Merger

Aug. 06, 2015

R&D

abCDe

	FINANCIAL ROUNDS

Total Capital Raised
abCDe

Financial Rounds

Numbers of Investors

Expand / Collapse All

Round

Date

Stage

Amount

Valuation

PIPE

Aug. 06, 2015

R&D

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Private Investor	abCDe
abC Defghij	Private Investor	abCDe	Led the round
abC Defghij	Private Investor	abCDe
abC Defghij	Private Investor	abCDe
abC Defghij	Private Investor	abCDe

Seed

Aug. 01, 2014

R&D

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Corporate Accelerator	abCDe
abC Defghij	Private Investor	abCDe

	R&D Grants

Expand / Collapse All

Round

Date

Stage

Amount

Remarks

R&D Grant

Jun. 01, 2014

R&D

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Bi-Lateral R&D Program	abCDe

	Non-Equity Assistance

Expand / Collapse All

Date

Stage

Remarks

Non-Equity Assistance

Jul. 08, 2014

R&D

Contributor	Type	Amount	Remarks
abC Defghij	Corporate Accelerator	abCDe

Non-Equity Assistance

Apr. 16, 2014

R&D

Contributor	Type	Amount	Remarks
abC Defghij	Corporate Accelerator	abCDe

	PORTFOLIO COMPANIES

Exits (1)

Company Name		Exit Type	Date Announced	Amount	Remarks
abC Defghij		Acquired	01/01/2019	abCDe

Last Updated:	abCDe
IVC Number:	abCDe